Furthermore, the Kaplan–Meier curves revealed significant differences in survival for KPNB1, with the higher expression having the poorer survival, not only in all glioma samples, but also the GBM sample subset (Supplementary Fig. 1b). This evidence concerns the gene KPNB1 and glioblastoma.